Skip to main navigation Skip to search Skip to main content

Deconvoluting the functional role of DNA methylation in trauma; Implications for epigenetic therapy and prospects of targeted “epigenetic therapy”

  • Gal Warhaftig
  • , Daniel Sapozhnikov
  • , Gal Yadid
  • , Moshe Szyf
  • McGill University

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Traumatic experience has long-term consequences, which manifest as posttraumatic stress disorder (PTSD). However, not all those exposed to the same trauma would be susceptible to developing PTSD; a majority of those exposed remain resilient. DNA methylation is a covalent modification of DNA that is associated with cell type differentiation; cell type–specific patterns form during embryonal development. Environmental and behavioral exposures are associated with alterations in DNA methylation patterns. Using a rat model of PTSD, we examined whether traumatic exposures alter DNA methylation in the brain, whether there is a difference in DNA methylation between “resilient” and “susceptible” individuals, and whether PTSD could be reversed by altering the expression of genes involved in DNA methylation alterations in susceptible animals. We present a new method for determining the causal role of specific DNA methylation alterations and for site-specific inhibition of DNA methylation.

Original languageEnglish
Title of host publicationSex, Gender, and Epigenetics
Subtitle of host publicationFrom Molecule to Bedside
PublisherElsevier
Pages81-92
Number of pages12
ISBN (Electronic)9780128239377
ISBN (Print)9780128239384
DOIs
StatePublished - 1 Jan 2023

Bibliographical note

Publisher Copyright:
© 2023 Elsevier Inc. All rights reserved.

Keywords

  • DNA methylation
  • DNMT3A
  • Early life adversity
  • Epigenetics
  • Glucocorticoid receptor
  • NAc
  • PTSD
  • Retinoic acid

Fingerprint

Dive into the research topics of 'Deconvoluting the functional role of DNA methylation in trauma; Implications for epigenetic therapy and prospects of targeted “epigenetic therapy”'. Together they form a unique fingerprint.

Cite this